Inventor · disambiguated record
Michael William Pride
Also filed as: PRIDE MICHAEL · PRIDE MICHAEL W · PRIDE MICHAEL WILLIAM
14 granted patents·11 pending applications·117 citations·filing 1993–2025
92Inventor score
Top patents by PatentIndex Score
25 records- 0196US9492559B2Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereofPFIZER·Filed 2015·Granted Nov 15, 2016·46 cites·45 claims
- 0295US11090375B2Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereofPFIZER·Filed 2020·Granted Aug 17, 2021·7 cites·4 claims
- 0394US11160855B2Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereofPFIZER·Filed 2016·Granted Nov 2, 2021·7 cites·48 claims
- 0493US11135279B2Immunogenic compositions for use in pneumococcal vaccinesPFIZER·Filed 2020·Granted Oct 5, 2021·3 cites·6 claims
- 0589US10786561B2Immunogenic compositions for use in pneumococcal vaccinesPFIZER·Filed 2016·Granted Sep 29, 2020·5 cites·16 claims
- 0688US11872274B2Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereofPFIZER·Filed 2021·Granted Jan 16, 2024·1 cites·16 claims
- 0787US10653764B2Immunogenic compositions for use in pneumococcal vaccinesPFIZER·Filed 2016·Granted May 19, 2020·6 cites·3 claims
- 0882US11413344B2Immunogenic compositions for use in pneumococcal vaccinesPFIZER·Filed 2018·Granted Aug 16, 2022·1 cites·10 claims
- 0981US6867000B2Method of enhancing immune responses to herpesWYETH CORP·Filed 2000·Granted Mar 15, 2005·14 cites·12 claims
- 1077US12318438B2Immunogenic compositions for use in pneumococcal vaccinesPFIZER·Filed 2022·Granted Jun 3, 2025·0 cites·20 claims
- 1176US2024238400A1Immunogenic compositions for use in pneumococcal vaccinesPFIZER·Filed 2024·Application pending·0 cites
- 1270US2024216495A1Compositions and methods for eliciting an immune response against clostridium difficilePFIZER·Filed 2023·Application pending·0 cites
- 1368US2021393764A1Immunogenic Compositions for Use in Pneumococcal VaccinesPFIZER·Filed 2021·Application pending·0 cites
- 1466US2025135006A1Amphiphilic tlr7/8 adjuvants and uses thereofPFIZER·Filed 2024·Application pending·0 cites
- 1565US2024189410A1Immunogenic compositions and methods for eliciting an immune response against clostridioides (clostridium) difficilePFIZER·Filed 2023·Application pending·0 cites
- 1664US2024374699A1Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses ThereofPFIZER·Filed 2023·Application pending·0 cites
- 1763US2025312432A1Compositions and methods for eliciting an immune response against clostridium difficilePFIZER·Filed 2025·Application pending·0 cites
- 1862US2020405837A1Immunogenic compositions for use in pneumococcal vaccinesPFIZER·Filed 2020·Application pending·0 cites
- 1961US5531990AMethod of raising an immune response with an anti-idiotypic antibody having correspondence with human hepatitis B surface antigenHEALTH RESEARCH INC·Filed 1993·Granted Jul 2, 1996·20 cites·1 claims
- 2057US2020254081A1Compositions and methods for eliciting an immune response against clostridium difficilePFIZER·Filed 2018·Application pending·0 cites
- 2155US2024000912A1Immunogenic compositions for use in pneumococcal vaccinesPFIZER·Filed 2021·Application pending·0 cites
- 2251US2022160859A1Compositions and methods for eliciting an immune response against clostridium difficilePFIZER·Filed 2020·Application pending·0 cites
- 2339US5744135AMethod of raising an immune response with an anti-idiotypic antibody having correspondence with human hepatitis B surface antigenHEALTH RESEARCH INC·Filed 1996·Granted Apr 28, 1998·4 cites·2 claims
- 2433US6319501B1Method of immunizing against hepatitis B virusHEALTH RESEARCH INC·Filed 1993·Granted Nov 20, 2001·2 cites·2 claims
- 2532US5668253APeptide having antigenic properties similar to "a "determinant of hepatitis B surface antigenHEALTH RESEARCH INC·Filed 1995·Granted Sep 16, 1997·1 cites·2 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →